Publication | Closed Access

Results of a Prospective Phase 2 Pilot Trial of 177Lu–PSMA-617 Therapy for Metastatic Castration-Resistant Prostate Cancer Including Imaging Predictors of Treatment Response and Patterns of Progression

UrologyGenitourinary CancerMedicineTreatment ResponseProspective Phase 2Cancer TreatmentProstatic DiseaseOncology177Lu–psma-617 TherapyRadiology